10-K Decoder · All companies

Teva Pharmaceutical Industries Limited

TEVA · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$17.3B$16.5B+4.3%
Operating income$2.16B−$303M
Net income$1.41B−$1.64B

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 3, 2026

$Q3 2026Year earlierChange
Revenue$4.39B$4.48B−1.9%
Operating income$714M$882M−19.0%
Net income$233M$433M−46.2%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Teva's revenue in FY2025?
$17.3B in FY2025 (Fiscal year ended Dec 31, 2025), +4.3% vs $16.5B a year earlier, per its 10-K filed Feb 2026.
Was Teva profitable in FY2025?
Yes: net income was $1.41B and operating income $2.16B in FY2025.
What was Teva's revenue in Q3 2026?
$4.39B (−1.9% vs a year earlier), per its Form 10-Q filed Nov 3, 2026.